Clinical Trial Detail

NCT ID NCT00831480
Title Everolimus(RAD001) For Advanced Renal Cell Carcinoma(RCC)Before Kidney Removal
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors Gilad Amiel
Indications

chromophobe renal cell carcinoma

papillary renal cell carcinoma

clear cell renal cell carcinoma

Therapies

Everolimus

Age Groups: adult

No variant requirements are available.